Residual Axillary Metastases in Node-Positive Breast Cancer Patients After Neoadjuvant Treatment: A Register-Based Study

CONCLUSIONS: Breast pCR or ITC only in TAD LNs can, with reasonable certainty, preclude more than three positive non-TAD LNs. Additionally, patients with only ITCs in the TAD LN had a low risk of having any non-TAD LN metastases after NACT. De-escalated axillary treatment may be considered in both subgroups.PMID:38704502 | DOI:10.1245/s10434-024-15354-1

Source: Ann Oncol - May 4, 2024 Category: Cancer & Oncology Authors: Frederikke Munck Maj-Britt Jensen Ilse Vejborg Maria K Gerlach Maja V Maraldo Niels T Kroman Tove H F Tvedskov Source Type: research